Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance Post ContentbdrxRead More You might also be interested in reading SA analyst upgrades/downgrades: TSLA, SMCI, LMT, HD. July 15, 2025 In Mainstream ← Previous post Next post →